Invited Speakers:
|
|
Dr. Axel Polack, General Partner, TVM Capital, Germany Aris Constantinides, Founder and Investment Director, NBGI Ventures, UK Philippe Jacon, CEO, Foundation for Innovative New Diagnostics (FIND), Switzerland Dr. Yin Qiman, Regulatory Affairs Director – Greater China, Beckman Coulter, China Dr. Simon Harworth, CEO, CompanDX & Founder Director, Team Kapital, UK Dr. Mingde Xia, Senior Director, Johnson & Johnson Corporate Office of Science and Technology, China Dr. Victor Shi, President, Asia Pacific, Qiagen, China Dr. Simon Harworth, CEO, CompanDX & Founder Director, Team Kapital, UK Kelvin Shao, VP of Marketing Development Center, Shanghai NewSummit Biopharma Group, China Dr. Jian Han, Faculty Investigator, HudsonAlpha Institute for Biotechnology; CEO, iRepertoire; President & CSO, iCubate, USA Dr. Thomas Li, Senior Director, US Chief Technology Office & Head of Asia Pacific Technology Management, Roche Diagnostics, USA Dr. Kfir Oved, CTO, MeMed Diagnostics, Israel Dr. Anthony Warford, Senior Lecturer in Cellular Pathology,School of Life Sciences, University of Westminster, UK Dr. Chi-Meng Tzeng, Executive Director and Full Professor,Translational Medicine Research Center, School of Pharmaceutical Sciences, Xiamen University, China; Chairman, Board of Technology, RBC Bioscience, BSI Biotech & VivaCell Prof. Michael Yang, Chair Professor, Department of Biology and Chemistry; Director, Biotech and Health Centre, City University of Hong Kong and Co-founder & Director, Multigene Diagnostics, Hong Kong Dr. Chris Pak, President & CEO, Molecular Targeting Technologies Inc, USA Dr. Huimin Kong, President & CEO, BioHelix Corp, USA Ashini Fernando, Staff Scientist, BD, Singapore Dr. Jonathan O’Halloran, Co-founder & CSO, QuantuMDx, UK
|
|